§ Federal grant opportunity · RFA-DC-28-002
Coordinating Center for National Resource Network for the Study of Human Auditory and Vestibular Disorders (U24 Clinical Trial Not Allowed)
National Institutes of Health is accepting applications for Coordinating Center for National Resource Network for the Study of Human Auditory and Vestibular Disorders (U24 Clinical Trial Not Allowed). The deadline is March 5, 2027 and the published award range is $200K.
Key facts
- Funder
- National Institutes of Health
- Application deadline
- March 5, 2027
- Award range
- $200K
- Eligibility
- federally recognized native american tribal governments, public and indian housing authorities, county governments, other native american tribal organizations, private institutions of higher education, nonprofits non higher education with 501c3, nonprofits non higher education without 501c3, small businesses, public and state institutions of higher education, other, special district governments, state governments, independent school districts, city or township governments, for profit organizations other than small businesses
- Geography
- United States
- Focus areas
- Health
- Opportunity number
- RFA-DC-28-002
Program overview
The objective of this Notice of Funding Opportunity (NOFO) is to support a coordinating center for the NIDCD National Human Ear Resource Network, a collaborative network that serves as a national technological resource for auditory and vestibular researchers to use human inner and middle ear tissues for a range of basic and clinical studies to advance knowledge and treatment of auditory and vestibular disorders.
How to apply
- Confirm your organization meets the eligibility criteria above.
- Read the full funding opportunity announcement from National Institutes of Health.
- Draft your narrative against the funder's stated priorities and review criteria.
- Submit before March 5, 2027, allowing time for registration and validation.
Related grant opportunities
- Opportunities for Collaborative Research at the NIH Clinical Center (U01 Clinical Trial Optional)
- High Priority HIV and Substance Use Research (R01 Clinical Trial Optional)
- NEA Arts and Artifacts International Indemnity Program 2, FY2027 (3/27)
- Continuation of the Cardiovascular Repository for-Type 1 Diabetes (CARE-T1D) Consortium U01 (Open Competition)- Research (U01, Clinical Trial Not Allowed)
- ROSES 2025: B.7 The Heliophysics Low-Cost Access to Space
Find every grant your organization qualifies for
Mavenly scores this opportunity against your mission, geography, and funding history — then drafts the proposal with you and tracks the deadline through submission and reporting.